Skip to content
Disclosery

EXANE DERIVATIVES: BKNG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BKNG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 10 BKNG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 10 shares
    Change vs previous 13F -73 shares

    0.01% of the 13F portfolio, value $17,488.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 83 shares
    Change vs previous 13F -10 shares

    0.05% of the 13F portfolio, value $194,923.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 93 shares
    Change vs previous 13F -19 shares

    0.05% of the 13F portfolio, value $223,136.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 112 shares
    Change vs previous 13F -42 shares

    0.07% of the 13F portfolio, value $265,882.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 154 shares
    Change vs previous 13F +6 shares

    0.08% of the 13F portfolio, value $337,026.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 148 shares
    Change vs previous 13F +146 shares

    0.1% of the 13F portfolio, value $344,829.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $4,455.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $3,421.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).